Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP327049.RAp97ZbBK3jAZF0DFeH_U6vq_yt0ZkbKSpOYMQ1gANZJ4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP327049.RAp97ZbBK3jAZF0DFeH_U6vq_yt0ZkbKSpOYMQ1gANZJ4130_assertion type Assertion NP327049.RAp97ZbBK3jAZF0DFeH_U6vq_yt0ZkbKSpOYMQ1gANZJ4130_head.
- NP327049.RAp97ZbBK3jAZF0DFeH_U6vq_yt0ZkbKSpOYMQ1gANZJ4130_assertion description "[To investigate catecholamine phenotypes and the effects of a tyrosine hydroxylase inhibitor in individuals with the 22q11.2 deletion syndrome and low-activity catechol-O-methyltransferase (COMT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP327049.RAp97ZbBK3jAZF0DFeH_U6vq_yt0ZkbKSpOYMQ1gANZJ4130_provenance.
- NP327049.RAp97ZbBK3jAZF0DFeH_U6vq_yt0ZkbKSpOYMQ1gANZJ4130_assertion evidence source_evidence_literature NP327049.RAp97ZbBK3jAZF0DFeH_U6vq_yt0ZkbKSpOYMQ1gANZJ4130_provenance.
- NP327049.RAp97ZbBK3jAZF0DFeH_U6vq_yt0ZkbKSpOYMQ1gANZJ4130_assertion SIO_000772 11502905 NP327049.RAp97ZbBK3jAZF0DFeH_U6vq_yt0ZkbKSpOYMQ1gANZJ4130_provenance.
- NP327049.RAp97ZbBK3jAZF0DFeH_U6vq_yt0ZkbKSpOYMQ1gANZJ4130_assertion wasDerivedFrom befree-2016 NP327049.RAp97ZbBK3jAZF0DFeH_U6vq_yt0ZkbKSpOYMQ1gANZJ4130_provenance.
- NP327049.RAp97ZbBK3jAZF0DFeH_U6vq_yt0ZkbKSpOYMQ1gANZJ4130_assertion wasGeneratedBy ECO_0000203 NP327049.RAp97ZbBK3jAZF0DFeH_U6vq_yt0ZkbKSpOYMQ1gANZJ4130_provenance.